0001209191-15-060391.txt : 20150710
0001209191-15-060391.hdr.sgml : 20150710
20150710135813
ACCESSION NUMBER: 0001209191-15-060391
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150708
FILED AS OF DATE: 20150710
DATE AS OF CHANGE: 20150710
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BOGER JOSHUA S
CENTRAL INDEX KEY: 0001197023
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 15983373
MAIL ADDRESS:
STREET 1: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-07-08
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001197023
BOGER JOSHUA S
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
1
0
0
0
Common Stock
2015-07-08
4
M
0
1300
17.16
A
346584
D
Common Stock
2015-07-08
4
M
0
10400
35.64
A
356984
D
Common Stock
2015-07-08
4
S
0
2836
121.64
D
354148
D
Common Stock
2015-07-08
4
S
0
3900
122.39
D
350248
D
Common Stock
2015-07-08
4
S
0
4264
123.47
D
345984
D
Common Stock
2015-07-08
4
S
0
400
124.21
D
345584
D
Common Stock
2015-07-08
4
S
0
300
125.38
D
345284
D
Common Stock
13286
I
401(k)
Common Stock
122700
I
Common Stock held in trust
Stock Option (right to buy)
17.16
2015-07-08
4
M
0
1300
0.00
D
2015-07-19
Common Stock
1300
1800
D
Stock Option (right to buy)
35.64
2015-07-08
4
M
0
10400
0.00
D
2016-02-01
Common Stock
10400
302400
D
Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $121.64 (range $121.00 to $121.97).
Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $122.39 (range $122.00 to $122.98).
Open market sales reported on this line occurred at a weighted average price of $123.47 (range $123.01 to $124.00).
Open market sales reported on this line occurred at a weighted average price of $124.21 (range $124.05 to $124.43).
Open market sales reported on this line occurred at a weighted average price of $125.38 (range $125.15 to $125.50).
Fully vested.
Omar White, Attorney-In-Fact
2015-07-10